Defects in the protein machinery responsible for the degradation and recycling of lysosomal substrates result in a group of human diseases collectively known as lysosomal storage disorders (LSDs). Despite advances in defining the genetic basis for LSDs, surprisingly little is known about the underlying mechanisms that lead to disease pathology. Identifying the sensitive biochemical pathways responsible for the developmental and progressive features of LSDs is essential since it will provide the underpinnings for new therapeutic strategies. The long-term goal of the proposed research is to investigate the molecular pathogenesis of mucolipidosis II (ML-II), the devastating LSD caused by defects in mannose 6-phosphate (M6P) biosynthesis. In an effort to link the cartilage defects associated with this disease to specific biochemical pathways, we have established a zebrafish model for ML-II that shares many of the pathologies noted in human patients, such as abnormalities in craniofacial cartilage development. The cartilage morphogenesis defects in these zebrafish are accompanied by alterations in i) chondrocyte differentiation, ii) deposition of type II collagen and iii) the expression of ECM modifying enzymes. Furthermore, we have noted changes in the secretion and storage of latent TGF-ss1 and integrity of fibronectin in ML-II patient fibroblasts. A specific role for the TGF-ss pathway in ML-II cartilage pathogenesis is further suggested by the fact i) TGF-ss growth factors are central to multiple aspects of cartilage development and homeostasis, ii) latent TGF-ss is M6P-modified and iii) the activation of latent TGF-ss complexes involves M6P receptor-mediated events. Using complementary zebrafish and cell- based approaches, we will test the hypothesis that M6P-dependent TGF-ss dysregulation and impaired ECM maintenance cause the abnormal cartilage development and homeostasis associated with ML-II. In the first aim, we will further elucidate the cellular mechanisms that underlie abnormal chondrogenesis in ML-II zebrafish. With the aid of in vivo confocal microscopy, we will investigate how the behavior of chondrocyte precursors is altered during craniofacial development in ML-II zebrafish and how changes in the expression of ECM proteins and regulators of ECM synthesis and turnover impact specific properties of chondrocytes within developing cartilage. In the second aim, we will take advantage of multiple cell culture systems to investigate the molecular mechanisms responsible for M6P-dependent TGF-ss dysregulation and fibronectin fragmentation, and how such events lead to the abnormal development and progressive destruction of cartilage noted in ML-II. In the third aim, we will assess the contribution of the cation-independent M6P receptor (CI-MPR) on TGF-ss regulation and cartilage development. A unique set of zebrafish CI-MPR mutants, restricted in their ability to bind specific ligands or properly traffic and internalize these ligands, will be introduced into CI-MPR null zebrafish and the resulting embryos analyzed on a phenotypic and cellular level with regard to cartilage development.
Despite advances in uncovering the genetic basis for many lysosomal storage disorders, surprisingly little is known about the underlying mechanisms that lead to disease pathology. Using the zebrafish model system, the broad goal of this proposal is to link the developmental and progressive bone and cartilage defects associated with these disorders with specific biochemical pathways. By doing so, we hope to identify novel therapeutic targets.
|Aarnio-Peterson, Megan; Zhao, Peng; Yu, Seok-Ho et al. (2017) Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting. J Biol Chem 292:15094-15104|
|Gurda, Brittney L; De Guilhem De Lataillade, Adrien; Bell, Peter et al. (2016) Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII. Mol Ther 24:206-216|
|Flanagan-Steet, Heather; Matheny, Courtney; Petrey, Aaron et al. (2016) Enzyme-specific differences in mannose phosphorylation between GlcNAc-1-phosphotransferase ?? and ? subunit deficient zebrafish support cathepsin proteases as early mediators of mucolipidosis pathology. Biochim Biophys Acta 1860:1845-53|
|Han, Sang-Oh; Pope, Rand; Li, Songtao et al. (2016) A beta-blocker, propranolol, decreases the efficacy from enzyme replacement therapy in Pompe disease. Mol Genet Metab 117:114-9|
|Flanagan-Steet, Heather; Aarnio, Megan; Kwan, Brian et al. (2016) Cathepsin-Mediated Alterations in TGFß-Related Signaling Underlie Disrupted Cartilage and Bone Maturation Associated With Impaired Lysosomal Targeting. J Bone Miner Res 31:535-48|
|Qian, Yi; van Meel, Eline; Flanagan-Steet, Heather et al. (2015) Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition. J Biol Chem 290:3045-56|
|Bammens, Riet; Mehta, Nickita; Race, Valérie et al. (2015) Abnormal cartilage development and altered N-glycosylation in Tmem165-deficient zebrafish mirrors the phenotypes associated with TMEM165-CDG. Glycobiology 25:669-82|
|Leroy, Jules G; Sillence, David; Wood, Tim et al. (2014) A novel intermediate mucolipidosis II/III?? caused by GNPTAB mutation in the cytosolic N-terminal domain. Eur J Hum Genet 22:594-601|
|Boccuto, Luigi; Aoki, Kazuhiro; Flanagan-Steet, Heather et al. (2014) A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet 23:418-33|
|Chu, Jaime; Mir, Alexander; Gao, Ningguo et al. (2013) A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation. Dis Model Mech 6:95-105|
Showing the most recent 10 out of 24 publications